These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 17501851)

  • 1. Mmp-9 immunoreactivity in acute migraine.
    Leira R; Sobrino T; Rodríguez-Yáñez M; Blanco M; Arias S; Castillo J
    Headache; 2007 May; 47(5):698-702. PubMed ID: 17501851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma matrix metalloproteinase-9 levels in migraineurs.
    Imamura K; Takeshima T; Fusayasu E; Nakashima K
    Headache; 2008 Jan; 48(1):135-9. PubMed ID: 18005141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different circulating metalloproteinases profiles in women with migraine with and without aura.
    Martins-Oliveira A; Speciali JG; Dach F; Marcaccini AM; Gonçalves FM; Gerlach RF; Tanus-Santos JE
    Clin Chim Acta; 2009 Oct; 408(1-2):60-4. PubMed ID: 19627981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum S100beta protein in children with acute recurrent headache: a potentially useful marker for migraine.
    Papandreou O; Soldatou A; Tsitsika A; Kariyannis C; Papandreou T; Zachariadi A; Papassotiriou I; Chrousos GP
    Headache; 2005; 45(10):1313-6. PubMed ID: 16324163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet levels of dopamine are increased in migraine and cluster headache.
    D'Andrea G; Granella F; Perini F; Farruggio A; Leone M; Bussone G
    Headache; 2006 Apr; 46(4):585-91. PubMed ID: 16643552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of migraine attacks on the blood-brain barrier.
    Gao HM; Li L; Zhang KL; Chen XH; Tian SQ; Zhang ZL
    Chin Med J (Engl); 2010 Sep; 123(18):2559-61. PubMed ID: 21034616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New implications of the proteolytic balance between matrix metalloproteinases and their tissue inhibitors in migraine with and without aura.
    Mannello F
    Clin Chim Acta; 2009 Nov; 409(1-2):1-3. PubMed ID: 19632213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific matrix metalloproteinase 9 (MMP-9) haplotype affect the circulating MMP-9 levels in women with migraine.
    Martins-Oliveira A; Gonçalves FM; Speciali JG; Fontana V; Izidoro-Toledo TC; Belo VA; Dach F; Tanus-Santos JE
    J Neuroimmunol; 2012 Nov; 252(1-2):89-94. PubMed ID: 22907074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic expression of matrix metalloproteinase-9 in patients with cerebral arteriovenous malformations.
    Starke RM; Komotar RJ; Hwang BY; Hahn DK; Otten ML; Hickman ZL; Garrett MC; Sisti MB; Lavine SD; Meyers PM; Solomon RA; Connolly ES
    Neurosurgery; 2010 Feb; 66(2):343-8; discussion 348. PubMed ID: 20087134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intensive atorvastatin therapy on prostaglandin E2 levels and metalloproteinase-9 activity in the plasma of patients with non-ST-elevation acute coronary syndrome.
    Gómez-Hernández A; Sánchez-Galán E; Ortego M; Martín-Ventura JL; Blanco-Colio LM; Tarín-Vicente N; Jiménez-Nacher JJ; López-Bescos L; Egido J; Tuñón J
    Am J Cardiol; 2008 Jul; 102(1):12-8. PubMed ID: 18572029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of clinical subtypes of migraine with aura.
    Eriksen MK; Thomsen LL; Olesen J
    Headache; 2006 Feb; 46(2):286-97. PubMed ID: 16492238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
    Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V
    Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSD, BBB and MMP-9 elevations: animal experiments versus clinical phenomena in migraine.
    Gupta VK
    Expert Rev Neurother; 2009 Nov; 9(11):1595-614. PubMed ID: 19903020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases during and outside of migraine attacks without aura.
    Ashina M; Tvedskov JF; Lipka K; Bilello J; Penkowa M; Olesen J
    Cephalalgia; 2010 Mar; 30(3):303-10. PubMed ID: 19614693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial progenitor cells: a new key for endothelial dysfunction in migraine.
    Rodríguez-Osorio X; Sobrino T; Brea D; Martínez F; Castillo J; Leira R
    Neurology; 2012 Jul; 79(5):474-9. PubMed ID: 22815557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of matrix metalloproteinase MMP-9 in the plasma and hematoma fluid of intracerebral hemorrhage patients].
    Wu CH; Huang FY; Wang KY; Huang SY; Yang RL; Li HZ; Lei HX; Lin JS; Wang JM; Yan XH
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):174-6. PubMed ID: 18361815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMP and TIMP alterations in asymptomatic and symptomatic severe recurrent carotid artery stenosis.
    Sapienza P; Borrelli V; di Marzo L; Cavallaro A
    Eur J Vasc Endovasc Surg; 2009 May; 37(5):525-30. PubMed ID: 19297218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of matrix metalloproteinase-9 in Henoch-Schönlein purpura.
    Zou CC; Zhao ZY; Tang LF; Liang L
    Scand J Rheumatol; 2006; 35(1):52-5. PubMed ID: 16467043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF-1, IGFBP-3, VEGF and MMP-9 levels and their potential relationship with renal functions in patients with compensatory renal growth.
    Yildiz B; Kural N; Colak O; Ak I; Akcar N
    Clin Physiol Funct Imaging; 2008 Mar; 28(2):107-12. PubMed ID: 18093232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute and interictal allodynia in patients with different headache forms: an Italian pilot study.
    Lovati C; D'Amico D; Bertora P; Rosa S; Suardelli M; Mailland E; Mariani C; Bussone G
    Headache; 2008 Feb; 48(2):272-7. PubMed ID: 18081821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.